awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36682843-54CCE6DD-1BA1-43CB-8AF7-ECE13C0B3335
Q36682843-54CCE6DD-1BA1-43CB-8AF7-ECE13C0B3335
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36682843-54CCE6DD-1BA1-43CB-8AF7-ECE13C0B3335
Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia.
P31
Q36682843-54CCE6DD-1BA1-43CB-8AF7-ECE13C0B3335
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36682843-54CCE6DD-1BA1-43CB-8AF7-ECE13C0B3335
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0125d5bf670555e0e448c650a2f4d17d0e83f994
P31
scholarly article